Scale | Hypothetical Range for Each Scale | Min Score for This Cohort* | Max Score for This Cohort* | % with Min Score | % with Max Score | Cronbach’s α⋄ |
---|---|---|---|---|---|---|
UCLA GIT 2.0* Reflux, n = 113 | 0.0–3.0 | 0.0 | 2.6 | 0.9 | 0.0 | 0.78 |
PROMIS Reflux*, n = 65 | 30.3–87.6 | 36.4† | 68.8† | 0.0 | 0.0 | 0.82 |
QOLRAD**, n = 110 | ||||||
Emotional distress | 1.0–7.0 | 1.7 | 7.0 | 0.0 | 0.9 | 0.95 |
Sleep disturbance | 1.0–7.0 | 1.0 | 7.0 | 0.9 | 0.9 | 0.96 |
FD problems | 1.0–7.0 | 1.5 | 7.0 | 0.0 | 0.9 | 0.93 |
PS function | 1.0–7.0 | 2.0 | 7.0 | 0.0 | 0.9 | 0.91 |
Vitality | 1.0–7.0 | 1.3 | 7.0 | 0.0 | 0.9 | 0.93 |
↵* Higher score denotes more GI symptoms;
↵** Lower score denotes more GI symptoms;
↵† Based on T score, so the min/max score for the cohort is different from the min/max score for the instrument.
↵⋄ Cronbach’s alpha reported to 2 decimal places as is standard reporting methodology. UCLA: University of California, Los Angeles; GIT: GI Tract; GERD: gastroesophageal reflux disease; PROMIS: Patient-Reported Outcome Measurement Information System; QOLRAD: Quality of Life in Reflux and Dyspepsia; FD: food and drink domain; PS: physical/social functioning.